DUBLIN--(BUSINESS WIRE)--Sep. 5, 2017--
Alkermes
plc (NASDAQ: ALKS) announced today that its Chief Financial Officer,
James Frates, will participate in a fireside chat at the Morgan Stanley
15th Annual Global Healthcare Conference on Monday, Sept. 11,
2017 at 10:30 a.m. ET (3:30 p.m. BST) from the Grand Hyatt New York. The
audio portion of the fireside chat may be accessed under the Investors
tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170905006076/en/
Source: Alkermes plc
Alkermes plc
Molly Cameron, +1-781-609-6143
Corporate
Communications
